tedharitbal的部落格

一名３５歲婦女連續做了二次試管嬰兒都出現流產現象，經醫師進一步檢查，發現她患有蛋白Ｓ缺乏症，經施打了支肝素ＬＭＷＨ治療，目前已懷孕１６週；婦產科蔡鋒博醫師指出，孕婦有嗜血栓性疾病時，常表現出習慣性流產或死產，這嗜血栓性疾病就是蛋白Ｓ缺乏症常見的一種。
婦產科醫師蔡鋒博說，一位來自韓國的台灣媳婦，曾接受二次試管嬰兒治療，卻在第六、七週時分別流產，轉介到醫學中心進一步檢查，發現她有抗磷脂質症候群及蛋白Ｓ缺乏症，在接受第三次試管嬰兒治療植入胚胎前，開始每天打兩支低劑量支肝素ＬＭＷＨ，連續打了２３０支，但胎兒已進入十六週較穩定期，已轉介至醫學中心繼續追蹤觀察，如果要順利生產，可能要打到６００支。
蔡鋒博說，蛋白Ｓ缺乏症發現於一九八四年，可能是遺傳或長期服用避孕藥等後天影響。有靜脈血栓病史者，約３％可以發現蛋白Ｓ缺乏症，不明原因習慣性死流產者，則約有１７．４％可以發現蛋白Ｓ缺乏症；另外飲食中維生素Ｂ６、Ｂ１２及葉酸攝取不足，也易造成血栓，導致蛋白Ｓ缺乏症，間接的影響懷孕。

A 35-year-old woman had a miscarriage in the second test-tube baby. After further examination by the doctor, she was found to have protein S deficiency. She was treated with heparin LMWH and was pregnant for 16 weeks. Obstetrics and Gynecology Cai Fengbo Physicians have pointed out that when pregnant women have thrombophilic diseases, they often show habitual abortion or stillbirth. This thrombophilic disease is a common type of protein S deficiency.
Obstetrician and gynecologist Cai Fengbo said that a Taiwanese wife from South Korea had undergone a second IVF treatment but had a miscarriage in the sixth and seventh weeks and referred it to the medical center for further examination. She found that she had antiphospholipid syndrome and Protein S deficiency, before the third IVF treatment of implanted embryos, began to hit two low-dose hepatic LMWH per day, 230 consecutive strokes, but the fetus has entered a relatively stable period of 16 weeks, has been referred to The medical center continues to follow the observations, and if it is to be produced smoothly, it may have to hit 600.
Cai Fengbo said that protein S deficiency was discovered in 1984 and may be acquired after genetic or long-term use of contraceptives. A history of venous thrombosis, about 3% can be found in protein S deficiency, unexplained habitual abortion, about 17.4% can be found in protein S deficiency; in addition, dietary intake of vitamin B6, B12 and folic acid is insufficient, It is also easy to cause thrombosis, leading to protein S deficiency, which indirectly affects pregnancy.

laennec is the ethical drug manufactured with JBP’s unique technologies.

laennec is the ethical drug manufactured with JBP’s unique technologies for effective extraction of variety of growth factors, cytokines, and other physiologically active substances from the human placenta. For instance, HGF (hepatocyte growth factor) promotes the proliferation of hepatic parenchymal cells for recovery of a damaged liver. Our product safety is ensured by the most rigid safety measures among existing scientific standards.